Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL

  1. Ruan, J.
  2. Moskowitz, A.
  3. Mehta-Shah, N.
  4. Sokol, L.
  5. Chen, Z.
  6. Kotlov, N.
  7. Nos, G.
  8. Sorokina, M.
  9. Maksimov, V.
  10. Sboner, A.
  11. Sigouros, M.
  12. van Besien, K.
  13. Horwitz, S.
  14. Rutherford, S.C.
  15. Mulvey, E.
  16. Revuelta, M.V.
  17. Xiang, J.
  18. Alonso, A.
  19. Melnick, A.
  20. Elemento, O.
  21. Inghirami, G.
  22. Leonard, J.P.
  23. Cerchietti, L.
  24. Martin, P.
Journal:
Blood

ISSN: 1528-0020 0006-4971

Year of publication: 2023

Volume: 141

Issue: 18

Pages: 2194-2205

Type: Article

DOI: 10.1182/BLOOD.2022018254 GOOGLE SCHOLAR

Sustainable development goals